Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cronin

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2011
Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivorsThomas P Ahern, Mariann Christensen, Deirdre P Cronin-Fenton, et al.
Plos One|March 17, 2017
Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patientsDaniella Klebaner, Stephen Hamilton-Dutoit, Thomas Ahern, et al.
Breast Cancer Research : BCR|November 5, 2021
Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control studyLindsay J Collin, Maret L Maliniak, Deirdre P Cronin-Fenton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2020
Early Discontinuation of Endocrine Therapy and Recurrence of Breast Cancer among Premenopausal WomenLindsay J Collin, Deirdre P Cronin-Fenton, Thomas P Ahern, et al.
Breast Cancer Research and Treatment|May 14, 2025
Genetic variants in tamoxifen metabolism and early treatment discontinuation among premenopausal breast cancer patientsKirsten M Woolpert, Thomas P Ahern, James W Baurley, et al.
Epidemiology (Cambridge, Mass.)|August 7, 2024
The Population-level Effect of Adjuvant Therapies on Breast Cancer Recurrence: Application of the Trend-in-Trend DesignLindsay J Collin, Lance A Waller, Deirdre P Cronin-Fenton, et al.
Journal of Cannabis Research|September 27, 2025
"It's legal, now what?" development, implementation, and evaluation of interdisciplinary cannabis education for healthcare traineesSean P Cronin, Josue Cruz, Elena Cameron, et al.
Journal of Child and Adolescent Psychopharmacology|February 13, 2002
Methodological issues in designing a multisite trial of risperidone in children and adolescents with autismL Scahill, J McCracken, C J McDougle, et al.
Acta Oncologica (Stockholm, Sweden)|November 1, 2019
17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based studyLindsay J Collin, Sinna P Ulrichsen, Thomas P Ahern, et al.
Child and Adolescent Psychiatric Clinics of North America|February 16, 2000
Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidoneC J McDougle, L Scahill, J T McCracken, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2011
Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivorsThomas P Ahern, Mariann Christensen, Deirdre P Cronin-Fenton, et al.
Plos One|March 17, 2017
Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patientsDaniella Klebaner, Stephen Hamilton-Dutoit, Thomas Ahern, et al.
Breast Cancer Research : BCR|November 5, 2021
Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control studyLindsay J Collin, Maret L Maliniak, Deirdre P Cronin-Fenton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2020
Early Discontinuation of Endocrine Therapy and Recurrence of Breast Cancer among Premenopausal WomenLindsay J Collin, Deirdre P Cronin-Fenton, Thomas P Ahern, et al.
Breast Cancer Research and Treatment|May 14, 2025
Genetic variants in tamoxifen metabolism and early treatment discontinuation among premenopausal breast cancer patientsKirsten M Woolpert, Thomas P Ahern, James W Baurley, et al.
Epidemiology (Cambridge, Mass.)|August 7, 2024
The Population-level Effect of Adjuvant Therapies on Breast Cancer Recurrence: Application of the Trend-in-Trend DesignLindsay J Collin, Lance A Waller, Deirdre P Cronin-Fenton, et al.
Journal of Cannabis Research|September 27, 2025
"It's legal, now what?" development, implementation, and evaluation of interdisciplinary cannabis education for healthcare traineesSean P Cronin, Josue Cruz, Elena Cameron, et al.
Journal of Child and Adolescent Psychopharmacology|February 13, 2002
Methodological issues in designing a multisite trial of risperidone in children and adolescents with autismL Scahill, J McCracken, C J McDougle, et al.
Acta Oncologica (Stockholm, Sweden)|November 1, 2019
17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based studyLindsay J Collin, Sinna P Ulrichsen, Thomas P Ahern, et al.
Child and Adolescent Psychiatric Clinics of North America|February 16, 2000
Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidoneC J McDougle, L Scahill, J T McCracken, et al.
Pageof 17